NGNE
Price
$14.96
Change
-$1.20 (-7.43%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
230.47M
SLN
Price
$5.81
Change
+$0.02 (+0.35%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
226.71M
45 days until earnings call
Interact to see
Advertisement

NGNE vs SLN

Header iconNGNE vs SLN Comparison
Open Charts NGNE vs SLNBanner chart's image
Neurogene
Price$14.96
Change-$1.20 (-7.43%)
Volume$3.7K
Capitalization230.47M
Silence Therapeutics
Price$5.81
Change+$0.02 (+0.35%)
Volume$672
Capitalization226.71M
NGNE vs SLN Comparison Chart in %
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NGNE vs. SLN commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Hold and SLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (NGNE: $16.16 vs. SLN: $5.79)
Brand notoriety: NGNE and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 203% vs. SLN: 88%
Market capitalization -- NGNE: $230.47M vs. SLN: $226.71M
NGNE [@Biotechnology] is valued at $230.47M. SLN’s [@Biotechnology] market capitalization is $226.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLN is a better buy in the long-term than NGNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 3 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • NGNE’s TA Score: 3 bullish, 6 bearish.
  • SLN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SLN is a better buy in the short-term than NGNE.

Price Growth

NGNE (@Biotechnology) experienced а -9.26% price change this week, while SLN (@Biotechnology) price change was -2.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

NGNE is expected to report earnings on May 09, 2025.

SLN is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($230M) and SLN($227M) have the same market capitalization . SLN YTD gains are higher at: -15.843 vs. NGNE (-29.309). SLN has higher annual earnings (EBITDA): -71.65M vs. NGNE (-77.68M). NGNE has more cash in the bank: 293M vs. SLN (137M). SLN has less debt than NGNE: SLN (60K) vs NGNE (13.5M). SLN has higher revenues than NGNE: SLN (27.7M) vs NGNE (925K).
NGNESLNNGNE / SLN
Capitalization230M227M101%
EBITDA-77.68M-71.65M108%
Gain YTD-29.309-15.843185%
P/E RatioN/AN/A-
Revenue925K27.7M3%
Total Cash293M137M214%
Total Debt13.5M60K22,500%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNESLN
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 26 days ago
84%
Bullish Trend 13 days ago
89%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUETX37.220.22
+0.59%
MFS Blended Research Core Equity R3
ITHAX43.270.25
+0.58%
Hartford Capital Appreciation A
TLATX11.600.06
+0.52%
Transamerica Large Core ESG I3
NVSCX31.190.06
+0.19%
Allspring Small Company Growth Admin
PQJCX13.70-0.02
-0.15%
PGIM Jennison Small-Cap Core Equity R6

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
-2.47%
BRNS - NGNE
51%
Loosely correlated
N/A
RNAZ - NGNE
48%
Loosely correlated
-2.92%
ZNTL - NGNE
45%
Loosely correlated
-6.35%
SNDX - NGNE
45%
Loosely correlated
-2.80%
IMNM - NGNE
45%
Loosely correlated
-0.23%
More